262 related articles for article (PubMed ID: 12659767)
21. Structurally Simple Phenanthridine Analogues Based on Nitidine and Their Antitumor Activities.
Qin SQ; Li LC; Song JR; Li HY; Li DP
Molecules; 2019 Jan; 24(3):. PubMed ID: 30691109
[TBL] [Abstract][Full Text] [Related]
22. Topoisomerase inhibitors as anticancer agents: a patent update.
Khadka DB; Cho WJ
Expert Opin Ther Pat; 2013 Aug; 23(8):1033-56. PubMed ID: 23611704
[TBL] [Abstract][Full Text] [Related]
23. Comparison of in vitro activities of camptothecin and nitidine derivatives against fungal and cancer cells.
Del Poeta M; Chen SF; Von Hoff D; Dykstra CC; Wani MC; Manikumar G; Heitman J; Wall ME; Perfect JR
Antimicrob Agents Chemother; 1999 Dec; 43(12):2862-8. PubMed ID: 10582872
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of topoisomerase IIalpha and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials.
Guo L; Liu X; Nishikawa K; Plunkett W
Mol Cancer Ther; 2007 May; 6(5):1501-8. PubMed ID: 17513599
[TBL] [Abstract][Full Text] [Related]
25. 11-Substituted Benzo[c]phenanthridines: New Structures and Insight into Their Mode of Antiproliferative Action.
Clement B; Girreser U; Steinhauer TN; Meier C; Marko D; Aichinger G; Kaltefleiter I; Stenzel L; Heber D; Weide M; Wolschendorf U; Zebothsen I; Zur Nieden D
ChemMedChem; 2016 Oct; 11(19):2155-2170. PubMed ID: 27546098
[TBL] [Abstract][Full Text] [Related]
26. The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.
Larsen AK; Grondard L; Couprie J; Desoize B; Comoe L; Jardillier JC; Riou JF
Biochem Pharmacol; 1993 Oct; 46(8):1403-12. PubMed ID: 8240389
[TBL] [Abstract][Full Text] [Related]
27. Exploring DNA topoisomerase I inhibition by the benzo[c]phenanthridines fagaronine and ethoxidine using steered molecular dynamics.
Clark RL; Deane FM; Anthony NG; Johnston BF; McCarthy FO; Mackay SP
Bioorg Med Chem; 2007 Jul; 15(14):4741-52. PubMed ID: 17517513
[TBL] [Abstract][Full Text] [Related]
28. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes.
Kobayashi Y; Yamashita Y; Fujii N; Takaboshi K; Kawakami T; Kawamura M; Mizukami T; Nakano H
Planta Med; 1995 Oct; 61(5):414-8. PubMed ID: 7480201
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jung MJ; Nam JM; Na Y; Cho WJ; Kwon Y; Lee ES
Bioorg Med Chem; 2010 Mar; 18(6):2245-2254. PubMed ID: 20188578
[TBL] [Abstract][Full Text] [Related]
30. Studies on the chemical constituents of rutaceous plants. LX. Development of a versatile method for syntheses of the antitumor benzo[c]phenanthridine alkaloids. (9). Efficient syntheses and antitumor activities of nitidine and related nonphenolic benzo[c]phenanthridine alkaloids.
Ishii H; Ichikawa Y; Kawanabe E; Ishikawa M; Ishikawa T; Kuretani K; Inomata M; Hoshi A
Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4139-51. PubMed ID: 4092262
[No Abstract] [Full Text] [Related]
31. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
[TBL] [Abstract][Full Text] [Related]
32. Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions.
Li TK; Bathory E; LaVoie EJ; Srinivasan AR; Olson WK; Sauers RR; Liu LF; Pilch DS
Biochemistry; 2000 Jun; 39(24):7107-16. PubMed ID: 10852708
[TBL] [Abstract][Full Text] [Related]
33. Substituted benz[a]acridines and benz[c]acridines as mammalian topoisomerase poisons.
Makhey D; Yu C; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem; 2000 May; 8(5):1171-82. PubMed ID: 10882027
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, Bacteriostatic and Anticancer Activity of Novel Phenanthridines Structurally Similar to Benzo[c]phenanthridine Alkaloids.
Lasák P; Motyka K; Kryštof V; Stýskala J
Molecules; 2018 Aug; 23(9):. PubMed ID: 30150591
[TBL] [Abstract][Full Text] [Related]
35. [DNA topoisomerases targeting anticancer agents and mechanism for acquirement of drug resistance].
Furukawa M; Harada T; Tanaka T; Kuwano M
Nihon Rinsho; 1997 May; 55(5):1096-102. PubMed ID: 9155159
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II.
Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.
Genès C; Lenglet G; Depauw S; Nhili R; Prado S; David-Cordonnier MH; Michel S; Tillequin F; Porée FH
Eur J Med Chem; 2011 Jun; 46(6):2117-31. PubMed ID: 21435753
[TBL] [Abstract][Full Text] [Related]
38. Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.
Bailly C; Lansiaux A; Dassonneville L; Demarquay D; Coulomb H; Huchet M; Lavergne O; Bigg DC
Biochemistry; 1999 Nov; 38(47):15556-63. PubMed ID: 10569939
[TBL] [Abstract][Full Text] [Related]
39. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
40. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
